Evidence map›Paper›PMID 39853697›Full record

ArticleChemMedChem2025

Machine Learning-Driven Discovery of Structurally Related Natural Products as Activators of the Cardiac Calcium Pump SERCA2a.

Carlos Cruz-Cortés, Eli Fernández-de Gortari, Rodrigo Aguayo-Ortiz, Jaroslava Šeflová, Adam Ard, Martin Clasby, Justus Anumonwo, L Michel Espinoza-Fonseca

Abstract read
In one paragraph

Article in ChemMedChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Development of activators for SERCA2a for heart failure treatments.European journal of medicinal chemistry · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carlos Cruz-CortésCenter for Arrhythmia Research, Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI-48109, USA.
Eli Fernández-de GortariInternational Iberian Nanotechnology Laboratory, Braga, 4715-330, Portugal.
Rodrigo Aguayo-OrtizDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, 04510, Mexico.
Jaroslava ŠeflováDepartment of Cell and Molecular Physiology, Loyola University Chicago, Maywood, IL-60153, USA.
Adam ArdCollege of Pharmacy, University of Michigan, Ann Arbor, MI-48109, USA.
Martin ClasbyCollege of Pharmacy, University of Michigan, Ann Arbor, MI-48109, USA.
Justus AnumonwoCenter for Arrhythmia Research, Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI-48109, USA.
L Michel Espinoza-FonsecaCenter for Arrhythmia Research, Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI-48109, USA.ORCID https://orcid.org/0009-0007-1006-6504

Funding

Hit-to-lead optimization for heart failure drug discoveryR01HL148068 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ESPINOZA-FONSECA, LENNANE MICHEL, HERRON, TODD JOSEPH · 2019 to 2022
$2.9M
Mechanisms and discovery of small-molecule effectors targeting cardiac ion pumpsR01HL176212 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Lennane Michel Espinoza-Fonseca · 2024 to 2026
$1.7M
Michigan Drug Discovery MDD2019202NHLBI NIH HHS R01 HL148068NHLBI NIH HHS R01 HL176212NIH HHS R01HL148068NIH HHS R01HL176212
6 · The paper itself

Abstract

A key molecular dysfunction in heart failure is the reduced activity of the cardiac sarcoplasmic reticulum Ca

Indexed as

Biological ProductsDrug DiscoveryMachine LearningSarcoplasmic Reticulum Calcium-Transporting ATPasesAnimalsCalciumDose-Response Relationship, DrugMiceMolecular StructureStructure-Activity RelationshipBiological ProductsCalciumSarcoplasmic Reticulum Calcium-Transporting ATPasescardiac calcium pumpheart failuremachine learningSERCA2asmall-molecule activatorsmall-molecule screening

Identifiers

PMID39853697
PMCPMC12058239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.